BeiGene
BGNE
#966
Rank
NZ$35.96 B
Marketcap
$328.75
Share price
0.49%
Change (1 day)
40.55%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Unfortunately we have no cost to borrow data for this company